Three Bridges, NJ, United States of America

Jessica J Liu


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2008-2010

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Jessica J Liu

Introduction

Jessica J Liu is an accomplished inventor based in Three Bridges, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target specific receptors in the body. With a total of 3 patents to her name, Liu's work is paving the way for new treatments in various medical conditions.

Latest Patents

One of her latest patents is focused on 3-spirocyclic indolyl derivatives, which are useful as ORL-1 receptor modulators. This invention is directed towards novel compounds that can be used in pharmaceutical compositions for treating disorders modulated by the ORL-1 receptor. Another significant patent involves substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compounds. This invention relates to compounds that serve as α/α-adrenoreceptor modulators, aimed at treating benign prostatic hypertrophy and lower urinary tract symptoms. The patent also covers pharmaceutical compositions containing these new compounds, along with methods for their preparation and use in medical treatments.

Career Highlights

Jessica J Liu is currently associated with Janssen Pharmaceutica NV, where she continues to innovate and contribute to the pharmaceutical industry. Her work is characterized by a strong focus on developing effective treatments for various health conditions.

Collaborations

Some of her notable coworkers include Peter J Connolly and Steven A Middleton, who collaborate with her on various projects within the company.

Conclusion

Jessica J Liu's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a leading inventor. Her work not only advances medical science but also offers hope for improved treatments for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…